Back
Design Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Buy
52
DSGN
Design Therapeutics
Last Price:
5.64
Seasonality Move:
-24.36%
Sell
29
NBY
NovaBay Pharmaceuticals
Last Price:
0.51
Seasonality Move:
-14.79%
Buy
52
Design Therapeutics (DSGN)
is a Buy
Is Design Therapeutics a Buy, Sell or Hold?
- The current Design Therapeutics [DSGN] share price is $5.77. The Score for DSGN is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- DSGN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
29
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.53. The Score for NBY is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DSGN Stock Price Chart
What is Design Therapeutics's stock price today?
-
The Design Therapeutics share price today is $5.77
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DSGN is experiencing slight buying pressure.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.53
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.
DSGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.28 | Buy |
| Relative Strength Index (14 RSI): | 62.68 | Buy |
| Chaikin Money Flow: | 20818 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.52 - 5.4) | Buy |
| Bollinger Bands (100): | (3.66 - 4.92) | Buy |
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.11 | Sell |
| Relative Strength Index (14 RSI): | 40.27 | Sell |
| Chaikin Money Flow: | 161961 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.47 - 0.53) | Buy |
| Bollinger Bands (100): | (0.64 - 3.4) | Sell |
DSGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.39 | Buy |
| 20-day SMA: | 5.09 | Buy |
| 50-day SMA: | 4.7 | Buy |
| 200-day SMA: | 3.57 | Buy |
| 8-day EMA: | 5.44 | Buy |
| 20-day EMA: | 5.12 | Buy |
| 50-day EMA: | 4.73 | Buy |
| 200-day EMA: | 4.18 | Buy |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.48 | Buy |
| 20-day SMA: | 0.49 | Buy |
| 50-day SMA: | 0.93 | Sell |
| 200-day SMA: | 3.89 | Sell |
| 8-day EMA: | 0.49 | Buy |
| 20-day EMA: | 0.53 | Sell |
| 50-day EMA: | 0.99 | Sell |
| 200-day EMA: | 8.5 | Sell |
Design Therapeutics Earnings Growth & DSGN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.39 per share, and a decrease next year of $0.26 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $13.87 per share, an increase next quarter of $0.05 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.
Design Therapeutics Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovaBay Pharmaceuticals Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||